155 related articles for article (PubMed ID: 7143370)
1. Phospholipid-nucleoside conjugates. 3. Syntheses and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin and selected 1-beta-D-arabinofuranosylcytosine 5-diphosphate-L-1,2-diacylglycerols.
Ryu EK; Ross RJ; Matsushita T; MacCoss M; Hong CI; West CR
J Med Chem; 1982 Nov; 25(11):1322-9. PubMed ID: 7143370
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
Matsushita T; Ryu EK; Hong CI; MacCoss M
Cancer Res; 1981 Jul; 41(7):2707-13. PubMed ID: 7248939
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
Hong CI; An SH; Schliselfeld L; Buchheit DJ; Nechaev A; Kirisits AJ; West CR
J Med Chem; 1988 Sep; 31(9):1793-8. PubMed ID: 3411602
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside conjugates. 6. Synthesis and comparison of antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids and selected lipophilic alcohols.
Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
J Med Chem; 1985 Feb; 28(2):171-7. PubMed ID: 3968680
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids.
Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
J Med Chem; 1990 May; 33(5):1380-6. PubMed ID: 2329558
[TBL] [Abstract][Full Text] [Related]
6. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
7. Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs.
Rosowsky A; Kim SH; Ross J; Wick MM
J Med Chem; 1982 Feb; 25(2):171-8. PubMed ID: 7057424
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Berdel WE
J Med Chem; 1986 Oct; 29(10):2038-44. PubMed ID: 3761322
[TBL] [Abstract][Full Text] [Related]
9. 1-beta-D-arabinofuranosylcytosine-phospholipid conjugates as prodrugs of Ara-C.
Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Ryu EK; MacCoss M
Cancer Drug Deliv; 1984; 1(3):181-90. PubMed ID: 6544120
[TBL] [Abstract][Full Text] [Related]
10. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
[TBL] [Abstract][Full Text] [Related]
11. 1-beta-D-arabinofuranosylcytosine conjugates of ether and thioether phospholipids. A new class of ara-C prodrug with improved antitumor activity.
Hong CI; West CR; Bernacki RJ; Tebbi CK; Berdel WE
Lipids; 1991 Dec; 26(12):1437-44. PubMed ID: 1819747
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic activity of 1-beta-D-arabinofuranosylcytosine conjugates of lipids in WEHI-3B leukemia in mice.
Berdel WE; Okamoto S; Danhauser-Riedl S; Hong CI; Winton EF; West CR; Rastetter J; Vogler WR
Exp Hematol; 1989 May; 17(4):364-7. PubMed ID: 2707318
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic activity of conjugates of lipids and 1-beta-D-arabinofuranosylcytosine.
Berdel WE; Danhauser S; Schick HD; Hong CI; West CR; Fromm M; Fink U; Reichert A; Rastetter J
Lipids; 1987 Nov; 22(11):943-6. PubMed ID: 3444389
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside conjugates as potential antitumor agents. 3. Synthesis and antitumor activity of 1-(beta-D-arabinofuranosyl)cytosine conjugates of corticosteroids.
Hong CI; Nechaev A; Kirisits AJ; Buchheit DJ; West CR
J Med Chem; 1980 Dec; 23(12):1343-7. PubMed ID: 7452687
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
[TBL] [Abstract][Full Text] [Related]
16. The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.
Rahman YE; Patel KR; Cerny EA; Maccoss M
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1105-12. PubMed ID: 6540691
[TBL] [Abstract][Full Text] [Related]
17. Influence of 1-beta-D-arabinofuranosylcytosine conjugates of lipids on the growth and metastasis of Lewis lung carcinoma.
Berdel WE; Danhauser S; Hong CI; Schick HD; Reichert A; Busch R; Rastetter J; Vogler WR
Cancer Res; 1988 Feb; 48(4):826-9. PubMed ID: 3338080
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
Lin TS; Yang JH; Liu MC; Shen ZY; Cheng YC; Prusoff WH; Birnbaum GI; Giziewicz J; Ghazzouli I; Brankovan V
J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
Nagahata T; Shibasaki C; Ishii T; Uchida T; Arakawa M; Kusama K; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]